GnuBio Licenses Microfluidics, Emulsion Methods for DNA Sequencing from Harvard

GnuBio, founded on technology developed by Harvard's David Weitz, aims to develop a scalable DNA sequencer that can analyze a human genome at 30-fold coverage for less than $100 in sequencing reagent costs, and small candidate gene regions at 100-fold coverage for less than $2 per sample.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.